12:40 PM EST - Pharmadrug Inc : Provides an update on multiple activities currently underway which support the Company's 'pipeline-in-a-pill' approach in the development of PD-001, its patented, orally bioavailable version of cepharanthine for the treatment of cancer and infectious disease. Pharmadrug Inc
shares C.PHRX are trading unchanged at $0.05.
